Incannex Healthcare Inc.
IXHL
$0.45
$0.0512.68%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/3/2025
-
Stocktwits News Feed
12/3/2025
-
Globe Newswire
12/1/2025
-
Zacks Investment Research
11/30/2025
-
MarketBeat
11/20/2025
-
Newsfile Corp. - News Releases
11/18/2025
-
TipRanks Financial Blog
11/2/2025
-
MarketBeat
11/1/2025
-
MarketBeat
10/30/2025
-
Globe Newswire
10/26/2025
-
MarketBeat
10/22/2025
-
GuruFocus
Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
10/22/2025
-
Globe Newswire
10/9/2025
-
MarketBeat
9/24/2025
-
Stocktwits News Feed
9/23/2025
-
MarketBeat
9/18/2025
-
MarketBeat
9/15/2025
-
MarketBeat
9/14/2025
-
MarketBeat
9/13/2025
-
MarketBeat
9/12/2025
-
MarketBeat
9/11/2025
-
MarketBeat
9/10/2025
-
MarketBeat
9/6/2025
-
MarketBeat
9/5/2025
-
MarketBeat
9/5/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
61 4 0984 0786
Address
8 Century Circuit
Suite 105 - Norwest
Sydney, NSW 2153
Suite 105 - Norwest
Sydney, NSW 2153
Country
Year Founded
--
Business Description
Sector
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in...
more